Liraglutide Powder ≥98% CAS No: 204656-20-2

Product Introduction

Product Name: Liraglutide Product purity: ≥ 99.0% CAS No: 204656-20-2 Molecular formula: C ₁₇₂ H ₂₆₅ N ₄∝ O ₅₁ Molecular weight: 3751.20 Da Detection method: HPLC Active ingredients: Liraglutide main chain+palmitoyl side chain Product Description: White to off white freeze-dried powder Product packaging: 1g/5g/10g sterile penicillin bottle (customizable) Product storage: -20 ℃± 5 ℃, avoid light and freeze Validity period: 36 months Declaration of Use: This product is intended for industrial use or scientific research only.

Products  Description 

Shaanxi Sunrise high-purity Liraglutide API

Shaanxi Sunrise focuses on providing high-quality Liraglutide raw materials that meet strict pharmaceutical standards. Our products adopt advanced and stable production processes, and the entire process follows the GMP quality management system to ensure high consistency between batches. The purity is stable at ≥ 99% (HPLC/MS), strictly meeting or exceeding the requirements of mainstream pharmacopoeias (such as EP/USP) for Liraglutide raw materials at home and abroad, and meeting the indicators (including related substances, peptide content, residual solvents, etc.).

Shaanxi Sunrise is committed to becoming your trusted supply chain partner, not only providing flexible supply capabilities from gram to kilogram levels to meet the needs of different stages of research and development and commercial production, but also focusing on product stability and safety to ensure the smooth development and production of your formulations.

Products Function

It provides high-purity Lilalutide API for the production of GLP-1 receptor agonist preparations for the treatment of type 2 diabetes and obesity.

Mechanism of Action

● Selective activation of glucagon like peptide-1 (GLP-1) receptors, mimicking the physiological effects of natural GLP-1.

● Long term design: By modifying with palmitoyl side chains, it resists degradation by dipeptidyl peptidase-4 (DPP-4) and extends the half-life to 13 hours. 

Key effects: 

✓ Glucose dependent promotion of insulin secretion 

✓ Inhibition of glucagon release ✓ Delayed gastric emptying, increased satiety 

✓ Protection of pancreatic beta cell function

Products Aplication

Diabetes treatment+In terms of obesity treatment

Pharmacological effects

● Pancreas: Increase β - cell proliferation and reduce apoptosis

● Cardiovascular: improve endothelial function and inhibit atherosclerosis

● Central nervous system: acts on the hypothalamic appetite center to regulate feeding behavior